No edit summary
No edit summary
Line 1: Line 1:
{{Medical Device
{{Medical Device
|Health Topic=Maternal mortality,
|Health Topic=Maternal mortality,
|Classification=Preventative
|Classification=Diagnosis
|Scope=Commercialized
|Scope=Commercialized
|Location=Africa, Asia, Australia, Europe, North America, South America
|Location=Africa, Asia, Australia, Europe, North America, South America

Revision as of 17:44, 10 November 2013

FA info icon.svg Angle down icon.svg Medical equipment data

Problem being addressed

Post-Partum hemorrhage is the cause for 8% of direct pregnancy-related deaths in industrialized countries and 25% of maternal deaths in the developing world. In trauma patients, hemorrhagic shock is the second most frequent cause of death.

Detailed description of the solution

This device is a low signal oximetry sensor that uses occlusion spectroscopy. Pressure is applied by a sensor around the finger, which obstructs blood flow. An optical signal is measured with a blood specific high signal to noise ratio. Therefore this device allows for accurate oximetry measurements even in times of low perfusion. It can measure glucose and hemoglobin levels as well as pulse rate.

Designed by

  • Designed and manufactured by: OriSense, located in Israel.

When and where it was tested/implemented

It was tested through multi center trials in cities across Europe and U.S.

References

Peer-reviewed publication

Other internally generated reports

Externally generated reports

Pulse oximetry. Fearnley S.J. (1995). Update in Anaesthesia Issue 5, article.

Pulse oximetry. Jubran A. (1999). Critical Care 3: R11-R17 Is Hypoxia common despite oxygen treatment in the Acute Medical Ward? Dhar R, Harrison RN, Snashall PD. (2006) Internet Journal of Medical update 1(2).

Cookies help us deliver our services. By using our services, you agree to our use of cookies.